GR78673B - - Google Patents

Info

Publication number
GR78673B
GR78673B GR72271A GR830172271A GR78673B GR 78673 B GR78673 B GR 78673B GR 72271 A GR72271 A GR 72271A GR 830172271 A GR830172271 A GR 830172271A GR 78673 B GR78673 B GR 78673B
Authority
GR
Greece
Application number
GR72271A
Other languages
Greek (el)
Inventor
Michael John Ashton
David Charles Cook
Colin James Daniels
Anthony Howard-Loveless
Jeremy David Pratt
Bernard Thomas Bull
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of GR78673B publication Critical patent/GR78673B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR72271A 1982-08-24 1983-08-22 GR78673B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24

Publications (1)

Publication Number Publication Date
GR78673B true GR78673B (en:Method) 1984-09-27

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
GR72271A GR78673B (en:Method) 1982-08-24 1983-08-22

Country Status (23)

Country Link
US (1) US4507315A (en:Method)
JP (1) JPS5955873A (en:Method)
KR (1) KR840005717A (en:Method)
AT (1) ATA301083A (en:Method)
AU (1) AU1818083A (en:Method)
BE (1) BE897580A (en:Method)
CA (1) CA1195993A (en:Method)
CS (1) CS240973B2 (en:Method)
DE (1) DE3330403A1 (en:Method)
DK (1) DK386783A (en:Method)
ES (2) ES525099A0 (en:Method)
FI (1) FI832989A7 (en:Method)
FR (1) FR2532310B1 (en:Method)
GB (1) GB2126225B (en:Method)
GR (1) GR78673B (en:Method)
IL (1) IL69544A0 (en:Method)
IT (1) IT1169775B (en:Method)
LU (1) LU84974A1 (en:Method)
NL (1) NL8302947A (en:Method)
NO (1) NO833024L (en:Method)
PT (1) PT77219B (en:Method)
SE (1) SE8304545L (en:Method)
ZA (1) ZA836191B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP1196385A1 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
EP1797083A1 (en) * 2004-09-24 2007-06-20 Janssen Pharmaceutica, N.V. Sulfonamide compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
GB2126225A (en) 1984-03-21
GB2126225B (en) 1985-10-09
LU84974A1 (fr) 1984-03-23
FI832989A0 (fi) 1983-08-22
CS612483A2 (en) 1985-06-13
DK386783A (da) 1984-02-25
GB8322539D0 (en) 1983-09-21
KR840005717A (ko) 1984-11-16
SE8304545D0 (sv) 1983-08-22
PT77219B (fr) 1986-02-04
CA1195993A (en) 1985-10-29
PT77219A (fr) 1983-09-01
US4507315A (en) 1985-03-26
DK386783D0 (da) 1983-08-23
NL8302947A (nl) 1984-03-16
FR2532310B1 (fr) 1986-01-10
ES8502691A1 (es) 1985-01-16
IT8322629A0 (it) 1983-08-24
ES528012A0 (es) 1985-06-16
ES8505935A1 (es) 1985-06-16
IT1169775B (it) 1987-06-03
SE8304545L (sv) 1984-02-25
AU1818083A (en) 1984-03-01
BE897580A (fr) 1984-02-23
ATA301083A (de) 1985-11-15
CS240973B2 (en) 1986-03-13
NO833024L (no) 1984-02-24
FR2532310A1 (fr) 1984-03-02
DE3330403A1 (de) 1984-03-01
JPS5955873A (ja) 1984-03-31
ES525099A0 (es) 1985-01-16
ZA836191B (en) 1984-04-25
IL69544A0 (en) 1983-11-30
FI832989A7 (fi) 1984-02-25

Similar Documents

Publication Publication Date Title
CH655690B (en:Method)
DE3241530C2 (en:Method)
FR2519260B3 (en:Method)
FR2520169B3 (en:Method)
FR2519437B1 (en:Method)
DE3382599D1 (en:Method)
CH655668B (en:Method)
CH655488B (en:Method)
DE3332129A1 (en:Method)
FR2519393B1 (en:Method)
DE3378479T2 (en:Method)
CH671133GA3 (en:Method)
FR2520189B3 (en:Method)
GR78673B (en:Method)
FR2519902B3 (en:Method)
FR2520115B1 (en:Method)
FR2519527B1 (en:Method)
FR2519941B3 (en:Method)
FR2519749B1 (en:Method)
DE3375436T (en:Method)
FR2519543B1 (en:Method)
CH652562GA3 (en:Method)
FR2519316B3 (en:Method)
DE3245333C2 (en:Method)
FR2519677B1 (en:Method)